Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
Year: 2020
BioDelivery Sciences to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a…
Better Choice Company to Host Third Quarter 2020 Financial Results Call on November 18 at 8:30 a.m. ET
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Cybin Inc. (NEO: CYBN)…
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting
–Preclinical data highlight Jounce’s approach to identify potential predictive and pharmacodynamic biomarkers to identify patients…
Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences
DUBLIN, Ireland, Nov. 11, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Receptor Life Sciences Names Gregory Mayes to Board of Directors
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Receptor Life Sciences (Receptor) today announced the appointment…
CymaBay Therapeutics to Present at Upcoming Investor Conferences
NEWARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
ORYZON to Present Further Positive Efficacy Data From Iadademstat ALICE Phase IIa Trial at the 62nd Congress of the American Society of Hematology
Will also present at Jefferies 2020 Virtual London Healthcare Conference CEO to participate in a…
Kronos Bio Announces Participation in the Jefferies Virtual London Healthcare Conference
SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sarcoma at CTOS 2020 Virtual Annual Meeting
Interim Phase 1 data in patients with relapsed/refractory Ewing sarcoma treated at the recommended Phase…
Spectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood Purification
Operating the SAMI viewed as both simple and safe by the nurses Successful remote deployment…
Kymera Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
WATERTOWN, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical…
NGM Bio to Present at Three Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq:…
Verizon and AWS Expand Mobile Edge Computing Platform to Dallas and Miami
What you need to know: Verizon and AWS add two additional 5G MEC cities bringing…
ORBCOMM Enhances “The ORBCOMM Platform” With Over 200 Features and Updates in 90 Days
Adds a host of incremental capabilities to enrich the customer experience and deliver greater data…